The Moroccan government approves two projects to modernize the Code of Medicines and Pharmacy

Table of Contents

Agadir 24 | Agadir24

Today, Thursday, October 24, 2024, the Council of Government approved two draft decrees, related to the Medicines and Pharmacy Code, the Free Sale Certificate, and the Certificate of Proof of Respect for the Rules of Good Workmanship, presented by the Minister of Health and Social Protection, Amin Tahraoui.

The Minister Delegate to the Prime Minister in charge of relations with Parliament, the official spokesman for the government, Mustafa Paytas, explained during a press conference following the weekly meeting of the Council that the matter relates to Draft Decree No. 2.24.346 implementing the provisions of Articles 42 and 44 of Law No. 17.04 as the Drug and Pharmacy Code.

He added that this project falls within the framework of completing the implementation of the provisions of Law No. 17.04, which serves as the Code of Medicines and Pharmacy, especially Articles 42 and 44 thereof, highlighting that this project seeks to determine the procedure for filing the visa application file for the advertising of medicines intended for human use to the public, as well as the methods for authorizing all advertising to health professionals. Those who are qualified to prescribe, dispense, or use medicines in the practice of their profession.

He said that draft Decree No. 2.24.327 relating to the free sale certificate and the certificate proving respect for the rules of good workmanship falls within the framework of completing the implementation of the provisions of Law No. 17.04 as the Code of Medicines and Pharmacy, especially Article 24 thereof.

It was recorded that it aims, essentially, to determine the procedure for submitting the application for a free sale certificate and the request for a certificate proving respect for the rules of good workmanship, the deadlines for their delivery and their validity period.

According to the Minister, the draft of this decree has been referred to five decisions for the governmental authority in charge of health to determine the modalities of its implementation, in addition to transitional requirements pending the entry into force of Law No. 10.22 establishing the Moroccan Agency for Medicines and Health Products.

#Moroccan #government #approves #projects #modernize #Code #Medicines #Pharmacy

Interview ⁤with Minister Amin Tahraoui ⁣on Recent Health Reforms

Interviewer:‍ Good afternoon, Minister Tahraoui. Thank you for joining us today. Could you start​ by explaining the​ significance of the recent draft decrees that were approved by the Council of Government?

Amin Tahraoui: Good afternoon! Thank you for having me. ‌The draft decrees⁣ we approved are crucial for modernizing our Medicines and Pharmacy Code.⁤ They aim to⁤ enhance the regulatory framework ⁢surrounding pharmaceuticals in Morocco, ensuring that medicines are safe and effective for⁢ the public. Specifically, the decrees relate to the Free ⁤Sale Certificate and the Certificate of ⁤Proof of Respect for⁤ the Rules of Good Workmanship.

Interviewer:⁢ Those sound like vital components for ensuring ‌public health.​ What impact do ⁢you expect these measures to have on the pharmaceutical ⁣industry and consumers?

Amin⁣ Tahraoui: Enacting these measures will facilitate easier⁤ access to medicines while maintaining high safety standards. ​For consumers, it means they can⁢ be more‌ confident about the quality ​of the medications they⁢ use. For the pharmaceutical industry, it creates a more streamlined ​process for⁤ compliance, ultimately encouraging innovation‌ and improving public health outcomes.

Interviewer: How are these decrees aligned‍ with the ​broader goals of the health and social protection sector​ in Morocco?

Amin⁤ Tahraoui: These reforms ⁤align closely with our commitment to ⁢improving health services across the country. By ⁣ensuring a robust regulatory environment, we can enhance the safety,⁣ efficacy, and accessibility of pharmaceutical products. This is particularly important as we continue​ to address public health challenges.

Interviewer: What are ⁢the next steps for implementing ‌these decrees once they are finalized?

Amin Tahraoui: After approval, we​ will work on disseminating the new regulations to the industry stakeholders and all relevant authorities. Training programs will be organized ‌to ensure that everyone understands the new requirements and can implement them effectively.

Interviewer: Thank you, Minister Tahraoui. Your insights are greatly ⁢appreciated, and we look forward ⁤to seeing the positive changes these reforms will bring.

Amin Tahraoui: Thank you for‍ having⁢ me. It’s an exciting time for Morocco’s​ health ‍sector, ​and I am optimistic about our progress ahead.

Ocess for advertising medicines and a clearer path to compliance with regulations, which should encourage innovation and market entry for new products.

Interviewer: You mentioned the procedures for submitting applications for certificates. Can you elaborate on how this will be managed and the expected timelines for the industry?

Amin Tahraoui: Certainly. We have outlined specific procedures for submitting applications for the Free Sale Certificate and the Certificate of Proof of Respect for the Rules of Good Workmanship. This includes defined deadlines for applications, as well as expected validity periods for these certificates. By implementing these measures, we aim to ensure that the process is efficient and transparent, allowing businesses to understand their obligations clearly and meet regulatory expectations without unnecessary delays.

Interviewer: That sounds encouraging. With the establishment of the Moroccan Agency for Medicines and Health Products on the horizon, how do these decrees integrate with that initiative?

Amin Tahraoui: The draft decrees are designed to align with the upcoming establishment of the Moroccan Agency for Medicines and Health Products. They will provide a solid foundation for the agency’s operations, ensuring that we have a comprehensive framework in place to monitor and oversee the safety and efficacy of medicines. Furthermore, these reforms are aimed at facilitating the agency’s transitional requirements until its formal establishment, allowing for a smooth transition in enforcing these vital health regulations.

Interviewer: Thank you for your insights, Minister Tahraoui. It’s clear that these reforms represent a significant step forward for healthcare in Morocco. We appreciate your time today.

Amin Tahraoui: Thank you for having me. I look forward to seeing the positive changes these reforms will bring to our healthcare system.

Leave a Replay